These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Childhood cancer--treatment at a cost. Ron E J Natl Cancer Inst; 2006 Nov; 98(21):1510-1. PubMed ID: 17077348 [No Abstract] [Full Text] [Related]
46. Increasing incidence of primary central nervous system tumors in the elderly: real increase or improved detection? Helseth A J Natl Cancer Inst; 1993 Nov; 85(22):1871-2. PubMed ID: 8230273 [No Abstract] [Full Text] [Related]
47. Focus on central nervous system neoplasia. Louis DN; Pomeroy SL; Cairncross JG Cancer Cell; 2002 Mar; 1(2):125-8. PubMed ID: 12086870 [No Abstract] [Full Text] [Related]
48. Neuropathological biopsy diagnoses in clinical practice: how thorough and reproducible are they? Ojeda VJ; al Moutaery KR Pathology; 1998 Aug; 30(3):328-9. PubMed ID: 9770206 [No Abstract] [Full Text] [Related]
49. A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan. Huang YC; Wei KC; Chang CH; Yang JT; Ho JT; Shen CC; Su CF; Cho DY; Ma HI; Lin JW; Lee EJ; Wu JJ; Tsai MD; Chang CK; Howng SL; Chang CN J Clin Neurosci; 2011 Jun; 18(6):784-8. PubMed ID: 21507649 [TBL] [Abstract][Full Text] [Related]
50. Racial differences in psychiatric comorbidities of rosacea: A large, urban academic center case-control study. Yi JZ; Pagani K; Lukac D; Li S; Chung HJ; McGee JS J Am Acad Dermatol; 2022 Aug; 87(2):448-451. PubMed ID: 34547357 [No Abstract] [Full Text] [Related]
51. Gliofibroma: a report of three cases and review of literature. Goyal S; Puri T; Gunabushanam G; Sharma MC; Sarkar C; Julka PK; Rath GK Acta Oncol; 2007; 46(8):1202-4. PubMed ID: 17851847 [No Abstract] [Full Text] [Related]
52. Psychiatric comorbidities associated with rosacea: a propensity score-matched case-control study in the All of Us database. Abdi P; Haq Z; Diaz MJ; Maibach HI Clin Exp Dermatol; 2024 Mar; 49(4):400-403. PubMed ID: 38011317 [No Abstract] [Full Text] [Related]
53. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873 [TBL] [Abstract][Full Text] [Related]
54. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey--Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Gupta MA; Gupta AK; Chen SJ; Johnson AM Br J Dermatol; 2005 Dec; 153(6):1176-81. PubMed ID: 16307654 [TBL] [Abstract][Full Text] [Related]
55. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. Aldrich N; Gerstenblith M; Fu P; Tuttle MS; Varma P; Gotow E; Cooper KD; Mann M; Popkin DL JAMA Dermatol; 2015 Nov; 151(11):1213-9. PubMed ID: 26307938 [TBL] [Abstract][Full Text] [Related]
56. Central nervous system tumors. Jacques G; Cormac O Handb Clin Neurol; 2013; 112():931-58. PubMed ID: 23622303 [TBL] [Abstract][Full Text] [Related]
57. Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis. Sanabria A; Kowalski LP; Shah JP; Nixon IJ; Angelos P; Williams MD; Rinaldo A; Ferlito A Head Neck; 2018 Apr; 40(4):855-866. PubMed ID: 29206325 [TBL] [Abstract][Full Text] [Related]
58. Rosacea and rhinophyma in the elderly. Wollina U Clin Dermatol; 2011; 29(1):61-8. PubMed ID: 21146734 [TBL] [Abstract][Full Text] [Related]
59. What is the real risk of central nervous system involvement in mantle cell lymphoma? Gill S; Seymour JF Leuk Lymphoma; 2008 Dec; 49(12):2237-9. PubMed ID: 19052969 [No Abstract] [Full Text] [Related]